Showing results (1-10 of 126) with videos related to
Sort By:
Pageof 13
Hormones (Athens, Greece)|November 14, 2019
Challenges and perspectives of selenium supplementation in Graves' disease and orbitopathyTomasz Bednarczuk, Lutz SchomburgEndokrynologia Polska|June 21, 2007
[The influence of vitamin D deficiency on cancers and autoimmune diseases development]Alina Kuryłowicz, Tomasz Bednarczuk, Janusz NaumanBest Practice & Research. Clinical Endocrinology & Metabolism|February 24, 2023
Genotype-phenotype correlations in Graves' diseaseMikołaj Radziszewski, Aleksander Kuś, Tomasz BednarczukCurrent Genomics|June 2, 2012
The genetic basis of graves' diseaseRafał Płoski, Konrad Szymański, Tomasz BednarczukEndokrynologia Polska|March 2, 2012
Adrenal imagingJoanna Podgórska, Andrzej Cieszanowski, Tomasz BednarczukEndokrynologia Polska|June 30, 2012
Coeliac disease in endocrine diseases of autoimmune originPiotr Miśkiewicz, Anna Kępczyńska-Nyk, Tomasz BednarczukPolski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|September 27, 2019
High dose intravenous methylprednisolone pulse therapy causes transient increase of serum calcium and phosphate levelsJoanna Rymuza, Michał Popow, Tomasz Bednarczuk, et al.Endokrynologia Polska|January 27, 2007
Predicting a relapse of Graves' hyperthyroidism in adults during the early phase of treatment with anti-thyroid drugsMarta Jonas, Urszula Ambroziak, Tomasz Bednarczuk, et al.European Thyroid Journal|August 16, 2021
Prevention of Iodinated Contrast Media-Induced Hyperthyroidism in Patients with Euthyroid GoiterKatarzyna Pelewicz, Rafał Wolny, Tomasz Bednarczuk, et al.Endokrynologia Polska|June 13, 2017
The influence of Graves' orbitopathy treatment with intravenous glucocorticoids on adrenal functionUrszula Ambroziak, Gabriela Bluszcz, Tomasz Bednarczuk, et al.Pageof 13